DaCapo Brainscience
Cambridge
About DaCapo Brainscience
DaCapo Brainscience is a biotechnology company focused on developing the first disease-modifying therapies for neurodegenerative diseases. With a mission centered on addressing the challenges of conditions such as Parkinson's disease, DaCapo Brainscience leverages deep expertise in the field to pioneer innovative treatments. The company's approach includes targeting the accumulation of specific proteins in the brain, which are associated with the progression of neurodegenerative diseases. DaCapo Brainscience is committed to advancing research and development to offer new paths forward for patients affected by these conditions. The team consists of professionals with extensive experience in biotechnology, working towards making significant contributions to the field of neuroscience.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.7M
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: dacapobrain.com
Industries & Categories
Biotechnology, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/dacapo-brainscience-82270 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.